346 related articles for article (PubMed ID: 22641218)
1. TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers.
Freudlsperger C; Bian Y; Contag Wise S; Burnett J; Coupar J; Yang X; Chen Z; Van Waes C
Oncogene; 2013 Mar; 32(12):1549-59. PubMed ID: 22641218
[TBL] [Abstract][Full Text] [Related]
2. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma.
Jackson-Bernitsas DG; Ichikawa H; Takada Y; Myers JN; Lin XL; Darnay BG; Chaturvedi MM; Aggarwal BB
Oncogene; 2007 Mar; 26(10):1385-97. PubMed ID: 16953224
[TBL] [Abstract][Full Text] [Related]
3. Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation.
Arsura M; Panta GR; Bilyeu JD; Cavin LG; Sovak MA; Oliver AA; Factor V; Heuchel R; Mercurio F; Thorgeirsson SS; Sonenshein GE
Oncogene; 2003 Jan; 22(3):412-25. PubMed ID: 12545162
[TBL] [Abstract][Full Text] [Related]
4. Nuclear NF-kappaB p65 phosphorylation at serine 276 by protein kinase A contributes to the malignant phenotype of head and neck cancer.
Arun P; Brown MS; Ehsanian R; Chen Z; Van Waes C
Clin Cancer Res; 2009 Oct; 15(19):5974-84. PubMed ID: 19789307
[TBL] [Abstract][Full Text] [Related]
5. Minocycline targets the NF-κB Nexus through suppression of TGF-β1-TAK1-IκB signaling in ovarian cancer.
Ataie-Kachoie P; Badar S; Morris DL; Pourgholami MH
Mol Cancer Res; 2013 Oct; 11(10):1279-91. PubMed ID: 23858099
[TBL] [Abstract][Full Text] [Related]
6. Aberrant IKKα and IKKβ cooperatively activate NF-κB and induce EGFR/AP1 signaling to promote survival and migration of head and neck cancer.
Nottingham LK; Yan CH; Yang X; Si H; Coupar J; Bian Y; Cheng TF; Allen C; Arun P; Gius D; Dang L; Van Waes C; Chen Z
Oncogene; 2014 Feb; 33(9):1135-47. PubMed ID: 23455325
[TBL] [Abstract][Full Text] [Related]
7. X-linked inhibitor of apoptosis (XIAP) inhibits c-Jun N-terminal kinase 1 (JNK1) activation by transforming growth factor beta1 (TGF-beta1) through ubiquitin-mediated proteosomal degradation of the TGF-beta1-activated kinase 1 (TAK1).
Kaur S; Wang F; Venkatraman M; Arsura M
J Biol Chem; 2005 Nov; 280(46):38599-608. PubMed ID: 16157589
[TBL] [Abstract][Full Text] [Related]
8. Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation.
Sethi G; Ahn KS; Pandey MK; Aggarwal BB
Blood; 2007 Apr; 109(7):2727-35. PubMed ID: 17110449
[TBL] [Abstract][Full Text] [Related]
9. A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA.
Bitzer M; von Gersdorff G; Liang D; Dominguez-Rosales A; Beg AA; Rojkind M; Böttinger EP
Genes Dev; 2000 Jan; 14(2):187-97. PubMed ID: 10652273
[TBL] [Abstract][Full Text] [Related]
10. Role of transforming growth factor-beta1-smad signal transduction pathway in patients with hepatocellular carcinoma.
Ji GZ; Wang XH; Miao L; Liu Z; Zhang P; Zhang FM; Yang JB
World J Gastroenterol; 2006 Jan; 12(4):644-8. PubMed ID: 16489684
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3.
Edlund S; Bu S; Schuster N; Aspenström P; Heuchel R; Heldin NE; ten Dijke P; Heldin CH; Landström M
Mol Biol Cell; 2003 Feb; 14(2):529-44. PubMed ID: 12589052
[TBL] [Abstract][Full Text] [Related]
12. ΔNp63 versatilely regulates a Broad NF-κB gene program and promotes squamous epithelial proliferation, migration, and inflammation.
Yang X; Lu H; Yan B; Romano RA; Bian Y; Friedman J; Duggal P; Allen C; Chuang R; Ehsanian R; Si H; Sinha S; Van Waes C; Chen Z
Cancer Res; 2011 May; 71(10):3688-700. PubMed ID: 21576089
[TBL] [Abstract][Full Text] [Related]
13. Attenuated transforming growth factor beta signaling promotes nuclear factor-kappaB activation in head and neck cancer.
Cohen J; Chen Z; Lu SL; Yang XP; Arun P; Ehsanian R; Brown MS; Lu H; Yan B; Diallo O; Wang XJ; Van Waes C
Cancer Res; 2009 Apr; 69(8):3415-24. PubMed ID: 19351843
[TBL] [Abstract][Full Text] [Related]
14. Role of Smad proteins in the regulation of NF-kappaB by TGF-beta in colon cancer cells.
Grau AM; Datta PK; Zi J; Halder SK; Beauchamp RD
Cell Signal; 2006 Jul; 18(7):1041-50. PubMed ID: 16288847
[TBL] [Abstract][Full Text] [Related]
15. A failure of transforming growth factor-beta1 negative regulation maintains sustained NF-kappaB activation in gut inflammation.
Monteleone G; Mann J; Monteleone I; Vavassori P; Bremner R; Fantini M; Del Vecchio Blanco G; Tersigni R; Alessandroni L; Mann D; Pallone F; MacDonald TT
J Biol Chem; 2004 Feb; 279(6):3925-32. PubMed ID: 14600158
[TBL] [Abstract][Full Text] [Related]
16. Fisetin, an inhibitor of cyclin-dependent kinase 6, down-regulates nuclear factor-kappaB-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein-regulated IkappaBalpha kinase activation.
Sung B; Pandey MK; Aggarwal BB
Mol Pharmacol; 2007 Jun; 71(6):1703-14. PubMed ID: 17387141
[TBL] [Abstract][Full Text] [Related]
17. Bortezomib-induced apoptosis with limited clinical response is accompanied by inhibition of canonical but not alternative nuclear factor-{kappa}B subunits in head and neck cancer.
Allen C; Saigal K; Nottingham L; Arun P; Chen Z; Van Waes C
Clin Cancer Res; 2008 Jul; 14(13):4175-85. PubMed ID: 18593997
[TBL] [Abstract][Full Text] [Related]
18. A positive feedback loop involving EGFR/Akt/mTORC1 and IKK/NF-kB regulates head and neck squamous cell carcinoma proliferation.
Li Z; Yang Z; Passaniti A; Lapidus RG; Liu X; Cullen KJ; Dan HC
Oncotarget; 2016 May; 7(22):31892-906. PubMed ID: 26895469
[TBL] [Abstract][Full Text] [Related]
19. Pinitol targets nuclear factor-kappaB activation pathway leading to inhibition of gene products associated with proliferation, apoptosis, invasion, and angiogenesis.
Sethi G; Ahn KS; Sung B; Aggarwal BB
Mol Cancer Ther; 2008 Jun; 7(6):1604-14. PubMed ID: 18566231
[TBL] [Abstract][Full Text] [Related]
20. Altered TAB1:I kappaB kinase interaction promotes transforming growth factor beta-mediated nuclear factor-kappaB activation during breast cancer progression.
Neil JR; Schiemann WP
Cancer Res; 2008 Mar; 68(5):1462-70. PubMed ID: 18316610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
